| Document |
Document Title |
|
WO/2020/189316A1 |
A compound according to the present invention, which is represented by formula (A) enables the achievement of an organic electroluminescent element that has more improved element performance. (In the formula, Ar, R1-R7, R11-R14, R21-R24,...
|
|
WO/2020/186421A1 |
Disclosed are a coordinate zirconium phosphotungstate catalyst and the use thereof in the catalytic hydrogenation of furfural, belonging to the field of heterogeneous catalysis. The zirconium phosphotungstate catalyst obtained in the pre...
|
|
WO/2020/190043A1 |
The present invention provides a method for producing 2,5-furandicarboxylic acid using catalysts, the method comprising: (a) a step for mixing fructose and an organic solvent to prepare a mixed solution; (b) a step for heating and reacti...
|
|
WO/2020/190034A1 |
The present invention relates to a novel naphthofuran derivative and a use of same. A compound of chemical formula 2 according to the present invention may be advantageously used in fluorescent dyes, in particular, in fluorescent dyes fo...
|
|
WO/2020/190080A1 |
The present invention relates to a method for the synthesis of 2,5-furandicarboxylic acid, and more specifically, the present invention relates to a more efficient and economical method capable of preparing 2,5-furandicarboxylic acid hav...
|
|
WO/2020/182070A1 |
Disclosed by the present invention are a compound using triarylamine that contains pyrene or azapyrene as a core and an application thereof. The structure of the organic compound provided by the present invention is as shown in general f...
|
|
WO/2020/185695A1 |
Disclosed herein are embodiments of a compound having a Formula I, or a salt, solvate, N-oxide, prodrug, diastereomer or enantiomer thereof. Also disclosed are derivative compounds made from the compound of Formula I. Certain derivative ...
|
|
WO/2020/184142A1 |
[Problem] To provide a compound which has high stability with respect to heat, high voltage holding ratio if used in a liquid crystal display element, and the like. [Solution] A compound which is represented by formula (1). In the formul...
|
|
WO/2020/176958A1 |
The present disclosure provides recombinant microorganisms and methods for the production of 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, an...
|
|
WO/2020/180019A1 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/180022A1 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/180624A1 |
Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein A, X1, X2, Q, R1, R2 and n are as defined herein. Such compounds function ...
|
|
WO/2020/176510A1 |
The present disclosure relates generally to certain diacylglycerol lactone compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds an...
|
|
WO/2020/175867A1 |
The present invention provides a novel compound and an organic light emitting device comprising same.
|
|
WO/2020/171480A1 |
The present invention is to provide: a novel compound that is useful as a material, in particular, a light-emitting material for an organic electronic device, in particular, an organic EL device; and an organic electronic device, in part...
|
|
WO/2020/168510A1 |
Disclosed is a method for preparing chiral butyrolactone. Specifically, according to the method, compound (II) is used as a raw material to sequentially perform loop-opening, sulfonylation, substitution, and loop-closing reactions to obt...
|
|
WO/2020/164340A1 |
Provided is a method for purifying 5-hydroxymethylfurfural. In the invention, 5-hydroxymethylfurfural is obtained by pumping a solution containing 5-hydroxymethylfurfural into a membrane separation device for filtration, collecting the f...
|
|
WO/2020/166874A1 |
The present invention provides a novel compound and an organic light-emitting diode using same.
|
|
WO/2020/166873A1 |
The present invention provides a novel compound and an organic light emitting device comprising same.
|
|
WO/2020/162442A1 |
Provided are: a novel compound having antibacterial activity; and a method for producing the same. The present invention relates to a compound represented by formula (I), or a salt or ester thereof.
|
|
WO/2020/162630A1 |
The purpose of the present disclosure is to provide a method for producing an organic compound, etc. Said purpose is solved by a method for producing a compound represented by formula (1). [In the formula, X represents -O-, an imino grou...
|
|
WO/2020/161760A1 |
The present invention provides: a novel compound having antimicrobial activity; and a method for producing same. Provided is a compound represented by formula (I), or a salt or an ester thereof.
|
|
WO/2020/161750A1 |
The present invention relates to hydrogenolysis process for preparation of 1,2-pentanediol from furfural. In particular, the present invention provides a conversion of 1,2-pentanediol from furfural in presence of methanol and using a cat...
|
|
WO/2020/161959A1 |
Provided is a naphthoquinone compound that exhibits antibacterial and antiviral activities against various fungi and bacteria. A compound represented by formula (I) [wherein: R1 is hydrogen or OR; and R is hydrogen, C1-6 alkyl or C1-6 al...
|
|
WO/2020/162693A1 |
The present invention relates to a self-healing infrared transmitting polyimide optical polymer material having a high refractive index, and a composite thereof, and prepares a novel chalcogen-based tetracarboxylic dianhydride compound r...
|
|
WO/2020/159279A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting element comprising same.
|
|
WO/2020/158841A1 |
The purpose of the present invention is to provide a novel compound capable of accelerating the proliferation of cells in cell culturing (particularly three-dimensional cell culturing). A hydrazide compound represented by formula (I) [wh...
|
|
WO/2020/156331A1 |
Provided is an application of compounds of any one or more of formula I, formula II and formula III in preparation of a drug for treating choriocarcinoma, belonging to the technical field of antitumor drugs. The compounds shown in formul...
|
|
WO/2020/157069A1 |
The present disclosure relates to compounds of Formula (I): and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inh...
|
|
WO/2020/160115A1 |
A method of making a biphenol dianhydride composition includes heating a first solution including a biphenol tetraacid of the formula (I) wherein Ra, Rb, p and q are as defined herein; at least one of sodium ions, potassium ions, calcium...
|
|
WO/2020/160132A1 |
A method for purification of a biphenol dianhydride composition includes contacting the biphenol dianhydride composition with a halogenated solvent to form a solution, and isolating the purified biphenol dianhydride composition from the ...
|
|
WO/2020/155558A1 |
Disclosed is a preparation method for furfural, relating to the technical field of bio-refining. The method is characterized by comprising the following preparation steps: 1) adding methyl alcohol to finely crushed corncob, and performin...
|
|
WO/2020/156330A1 |
Provided is an application of compounds of any one or more of formula I, formula II and formula III in preparation of a drug for treating brain malignant gliomas or melanoma, belonging to the technical field of antitumor drugs. The compo...
|
|
WO/2020/160215A1 |
A method for the purification of a bisphenol A dianhydride composition includes contacting the bisphenol A dianhydride composition with a halogenated solvent to form a solution, and one or more of filtering the solution to remove ionic s...
|
|
WO/2020/157463A1 |
Disulphide compounds of Formula (I) where Y is sulphuryl or sulphinyl Z is phenyl or substituted phenyl and the other variables are as defined in the claims; pharmaceutical compositions comprising these compounds and methods for making t...
|
|
WO/2020/154499A1 |
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: (Formula AA) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
|
|
WO/2020/151687A1 |
Provided is an N-benzyl-N-arylsulfonamide derivative, which is an N-benzyl-N-arylsulfonamide compound represented by a general formula (I), or a pharmaceutically acceptable salt or solvate thereof. The N-benzyl-N-arylsulfonamide derivati...
|
|
WO/2020/151500A1 |
Disclosed herein are an organic electroluminescent compound, an electroluminescent material and an organic electroluminescent component. The organic electroluminescent compound has the structure of formula (1). The organic electrolumines...
|
|
WO/2020/153650A1 |
The present invention relates to an anthracene derivative represented by [chemical formula A], and an organic light emitting element comprising same, wherein substituents R1- R5, R and R11-R18, L1 and n in [chemical formula A] are the sa...
|
|
WO/2020/148325A1 |
The present invention relates to amine, carboxamide or thioamide containing compounds which bind to the liver X receptor (LXRα and/or LXRβ) and act preferably as inverse agonists of LXR. The compounds are of formula (I) wherein rings A...
|
|
WO/2020/149710A1 |
The present invention provides: a compound represented by chemical formula 1; an organic electronic element including a first electrode, a second electrode, and an organic layer formed between the first electrode and the second electrode...
|
|
WO/2020/148404A1 |
The invention discloses a method for preparation of 1,4-sorbitan by dehydration of D-sorbitol in aqueous medium, wherein one equivalent of water is removed and a cyclization occurs, followed by a treatment with ethanol and isopropanol.
|
|
WO/2020/149711A1 |
The present invention provides: a compound represented by chemical formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrod...
|
|
WO/2020/145627A1 |
Provided is a method for preparing glufosinate, comprising the steps of: preparing a first intermediate compound by reacting L-homoserine in the presence of a first acid catalyst; preparing a second intermediate compound by reacting the ...
|
|
WO/2020/145514A1 |
Provided is a method of producing L-glufosinate from an L-lactone derivative compound, wherein the method of producing L-glufosinate comprises: a step of preparing a compound of chemical formula 2 from a compound of chemical formula 1 (s...
|
|
WO/2020/145513A1 |
Provided are an L-glufosinate intermediate preparation method or an L-glufosinate preparation method, the method, for preparing an L-glufosinate intermediate or an L-glufosinate from an L-homoserine derivative, comprising a step of prepa...
|
|
WO/2020/146568A1 |
A method for the synthesis of diazabicyclo[6.2.0]decane compounds is provided. The synthesis proceeds by stereoselective synthesis of a chiral lactone followed by azetidine formation via a series of chemoselective reactions. Bicyclizatio...
|
|
WO/2020/140675A1 |
Disclosed is a preparation method for 2,5-Furan dicarboxylic acid, using 2,5- dicarbonyl Furan (DFF) as the raw material; and DFF is catalyzed-oxidized using an oxidant to prepare FDCA in the presence of a composite catalyst containing a...
|
|
WO/2020/139525A1 |
Pharmaceutical compositions are described, the compositions comprising an immunosuppressant (such as mycophenolic acid) in combination with a very low concentration of a corticosteroid (such as betamethasone) that are capable of treating...
|
|
WO/2020/138837A1 |
The present invention relates to a compound represented by chemical formula 1, an organic optoelectronic device, and a display device.
|
